tirzepatide eye problems Semaglutide, Linked to Small Increase in Disorder Risk Weight-Loss Drug Linked to Lower

This pressure was felt slightly more by women (62%) than men (59%) and increased in younger generations (Gen Z: 64%, millennials: 67%, Gen X: 55%)

Inject it subcutaneously (just into the fat layer under the skin) into your abdomen, the front of your thigh, or your upper arm

Endotext [Internet] Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M (2023) Risk of Gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss

Diabetes raises your risk of developing high blood pressure, which puts further strain on your heart

The MHRA and EMA continuously monitor semaglutide safety through pharmacovigilance programmes and the Yellow Card Scheme